Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Prokidney (PROK) Shares Outstanding (Diluted Average) (2022 - 2025)

Prokidney (PROK) has disclosed Shares Outstanding (Diluted Average) for 4 consecutive years, with $131.6 million as the latest value for Q3 2025.

  • On a quarterly basis, Shares Outstanding (Diluted Average) rose 49.84% to $131.6 million in Q3 2025 year-over-year; TTM through Sep 2025 was $131.6 million, a 49.84% increase, with the full-year FY2024 number at $97.9 million, up 58.66% from a year prior.
  • Shares Outstanding (Diluted Average) was $131.6 million for Q3 2025 at Prokidney, up from $130.7 million in the prior quarter.
  • In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $131.6 million in Q3 2025 to a low of $6.2 million in Q2 2022.
  • A 4-year average of $78.0 million and a median of $63.1 million in 2023 define the central range for Shares Outstanding (Diluted Average).
  • Peak YoY movement for Shares Outstanding (Diluted Average): surged 932.82% in 2023, then dropped 0.96% in 2024.
  • Prokidney's Shares Outstanding (Diluted Average) stood at $61.5 million in 2022, then rose by 0.28% to $61.7 million in 2023, then soared by 58.66% to $97.9 million in 2024, then skyrocketed by 34.39% to $131.6 million in 2025.
  • Per Business Quant, the three most recent readings for PROK's Shares Outstanding (Diluted Average) are $131.6 million (Q3 2025), $130.7 million (Q2 2025), and $129.0 million (Q1 2025).